Evidence map›Paper›PMID 34408776›Full record

ArticleFrontiers in genetics2021

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.

Nan Wang, Yuanting Gu, Jiangrui Chi, Xinwei Liu, Youyi Xiong, Chaochao Zhong, Fang Wang, Xinxing Wang, Lin Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nan WangDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yuanting GuDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jiangrui ChiDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xinwei LiuDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Youyi XiongDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chaochao ZhongDepartment of Plastic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Fang WangDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xinxing WangDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lin LiDepartment of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformatics and computational biologybiomarker discoveryDNA damage responseprognostic modeltriple-negative breast cancer

Identifiers

PMID34408776
PMCPMC8365772
OpenAlexW3166698421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.